Suchen
Revolution Medicines Inc
RVMDZur Watchlist hinzufügen
184.000USD
-4.070-2.16%
Handelsschluss 07-28 16:00（ET）Kurse um 15 Minuten verzögert
36.25BMarktkapitalisierung
VerlustKGV TTM
Aktionärsstatistik
Aktualisiert: Wed, May 13
Aktualisiert: Wed, May 13
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Farallon Capital Management, L.L.C.
6.86%
Janus Henderson Investors
5.79%
Baker Bros. Advisors LP
4.45%
Fidelity Management & Research Company LLC
4.04%
Vanguard Capital Management, LLC
3.93%
Andere
74.93%
Aktionäre
Aktionäre
Anteil
Farallon Capital Management, L.L.C.
6.86%
Janus Henderson Investors
5.79%
Baker Bros. Advisors LP
4.45%
Fidelity Management & Research Company LLC
4.04%
Vanguard Capital Management, LLC
3.93%
Andere
74.93%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
34.84%
Hedge Fund
28.35%
Investment Advisor/Hedge Fund
21.99%
Venture Capital
3.03%
Research Firm
2.26%
Individual Investor
1.89%
Private Equity
1.72%
Sovereign Wealth Fund
1.17%
Bank and Trust
0.82%
Andere
3.93%
Institutionelle Beteiligung
Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
789
218.01M
102.55%
+11.03M
2025Q4
666
202.03M
104.50%
-3.01M
2025Q3
593
193.98M
100.35%
-10.39M
2025Q2
569
198.78M
106.34%
-10.16M
2025Q1
578
202.67M
108.85%
-6.24M
2024Q4
550
200.50M
107.86%
+9.16M
2024Q3
508
178.03M
106.09%
-11.19M
2024Q2
474
175.13M
105.71%
-4.08M
2024Q1
450
165.87M
97.52%
-10.22M
2023Q4
413
166.29M
101.77%
+33.45M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Farallon Capital Management, L.L.C.
14.58M
7.36%
-42.90K
-0.29%
Dec 31, 2025
Janus Henderson Investors
12.30M
6.21%
+947.45K
+8.34%
Dec 31, 2025
Baker Bros. Advisors LP
9.46M
4.77%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
8.59M
4.33%
-813.33K
-8.65%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
7.92M
4%
+426.25K
+5.69%
Dec 31, 2025
Nextech Invest, Ltd.
7.60M
3.84%
--
--
Dec 31, 2025
Wellington Management Company, LLP
6.99M
3.53%
-2.83M
-28.80%
Dec 31, 2025
Paradigm BioCapital Advisors LP
6.64M
3.35%
+421.11K
+6.77%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Tema Oncology ETF
9.9%
iShares Genomics Immunology and Healthcare ETF
5.38%
State Street SPDR S&P Biotech ETF
3.83%
Harbor Health Care ETF
2.62%
ProShares Ultra Nasdaq Biotechnology
1.77%
Tema Heart & Health ETF
1.75%
Direxion Daily S&P Biotech Bull 3X Shares
1.59%
Invesco Nasdaq Biotechnology ETF
1.07%
Virtus LifeSci Biotech Clinical Trials ETF
0.97%
iShares Biotechnology ETF
0.84%
Mehr Anzeigen
Tema Oncology ETF
Anteil9.9%
iShares Genomics Immunology and Healthcare ETF
Anteil5.38%
State Street SPDR S&P Biotech ETF
Anteil3.83%
Harbor Health Care ETF
Anteil2.62%
ProShares Ultra Nasdaq Biotechnology
Anteil1.77%
Tema Heart & Health ETF
Anteil1.75%
Direxion Daily S&P Biotech Bull 3X Shares
Anteil1.59%
Invesco Nasdaq Biotechnology ETF
Anteil1.07%
Virtus LifeSci Biotech Clinical Trials ETF
Anteil0.97%
iShares Biotechnology ETF
Anteil0.84%